Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ·Healthcare·Biotechnology
$6.08
—
Mkt Cap $1.03B
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (7 analysts)
$13.50
Range $9.00 – $18.00
Implied Upside
+122.0%
Consensus $13.50 vs current $6.08
NASDAQ·Healthcare·Biotechnology
$6.08
—
Mkt Cap $1.03B
Buy
4
Hold
1
Sell
0
Price Target (7 analysts)
$13.50
Range $9.00 – $18.00
+122.0%
Consensus $13.50 vs current $6.08